SHREE GANESH REMEDIES
|
SHREE GANESH REMEDIES Last 5 Year Income Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| INCOME : | ||||
| Gross Sales | ₹129 Cr | ₹6,401,872 Cr | ₹35 Cr | ₹35 Cr |
| Sales | ₹128 Cr | ₹6,401,872 Cr | ₹35 Cr | ₹35 Cr |
| Job Work/ Contract Receipts | - | - | - | - |
| Processing Charges / Service Income | - | - | - | - |
| Revenue from property development | - | - | - | - |
| Other Operational Income | ₹1.09 Cr | - | - | - |
| Less: Excise Duty | - | - | - | - |
| Net Sales | ₹126 Cr | ₹6,401,872 Cr | ₹35 Cr | ₹35 Cr |
| EXPENDITURE : | ||||
| Increase/Decrease in Stock | ₹-4.88 Cr | ₹-39,340 Cr | ₹-1.98 Cr | ₹-1.98 Cr |
| Raw Material Consumed | ₹62 Cr | ₹3,830,818 Cr | ₹20 Cr | ₹20 Cr |
| Opening Raw Materials | ₹8.48 Cr | ₹220,411 Cr | ₹1.64 Cr | ₹1.64 Cr |
| Purchases Raw Materials | ₹63 Cr | ₹3,712,176 Cr | ₹21 Cr | ₹21 Cr |
| Closing Raw Materials | ₹10 Cr | ₹101,769 Cr | ₹1.89 Cr | ₹1.89 Cr |
| Other Direct Purchases / Brought in cost | ₹1.28 Cr | - | - | - |
| Other raw material cost | - | - | - | - |
| Power & Fuel Cost | ₹6.39 Cr | ₹154,387 Cr | ₹0.85 Cr | ₹0.85 Cr |
| Electricity & Power | ₹6.39 Cr | ₹143,413 Cr | ₹0.79 Cr | ₹0.79 Cr |
| Oil, Fuel & Natural gas | - | ₹4,343 Cr | ₹0.05 Cr | ₹0.05 Cr |
| Coals etc | - | - | - | - |
| Other power & fuel | - | ₹6,632 Cr | ₹0.02 Cr | ₹0.02 Cr |
| Employee Cost | ₹8.41 Cr | ₹289,908 Cr | ₹1.63 Cr | ₹1.63 Cr |
| Salaries, Wages & Bonus | ₹7.66 Cr | ₹264,075 Cr | ₹1.51 Cr | ₹1.51 Cr |
| Contributions to EPF & Pension Funds | ₹0.29 Cr | ₹12,591 Cr | ₹0.07 Cr | ₹0.07 Cr |
| Workmen and Staff Welfare Expenses | ₹0.30 Cr | ₹6,488 Cr | ₹0.03 Cr | ₹0.03 Cr |
| Other Employees Cost | ₹0.16 Cr | ₹6,754 Cr | ₹0.03 Cr | ₹0.03 Cr |
| Other Manufacturing Expenses | ₹4.82 Cr | ₹69,661 Cr | ₹0.56 Cr | ₹0.56 Cr |
| Sub-contracted / Out sourced services | ₹0.46 Cr | - | - | - |
| Processing Charges | ₹2.05 Cr | - | - | - |
| Repairs and Maintenance | ₹0.80 Cr | - | - | - |
| Packing Material Consumed | ₹1.03 Cr | ₹49,329 Cr | ₹0.44 Cr | ₹0.44 Cr |
| Other Mfg Exp | ₹0.47 Cr | ₹20,333 Cr | ₹0.12 Cr | ₹0.12 Cr |
| General and Administration Expenses | ₹2.48 Cr | ₹693,101 Cr | ₹3.69 Cr | ₹3.69 Cr |
| Rent , Rates & Taxes | ₹1.17 Cr | ₹13,804 Cr | ₹0.12 Cr | ₹0.12 Cr |
| Insurance | ₹0.10 Cr | ₹6,380 Cr | ₹0.06 Cr | ₹0.06 Cr |
| Printing and stationery | - | ₹3,899 Cr | ₹0.02 Cr | ₹0.02 Cr |
| Professional and legal fees | ₹0.69 Cr | ₹19,757 Cr | ₹0.19 Cr | ₹0.19 Cr |
| Traveling and conveyance | ₹0.08 Cr | ₹5,287 Cr | ₹0.04 Cr | ₹0.04 Cr |
| Other Administration | ₹0.45 Cr | ₹643,974 Cr | ₹3.26 Cr | ₹3.26 Cr |
| Selling and Distribution Expenses | ₹3.95 Cr | ₹123,339 Cr | ₹1.18 Cr | ₹1.18 Cr |
| Advertisement & Sales Promotion | ₹1.36 Cr | ₹13,226 Cr | ₹0.11 Cr | ₹0.11 Cr |
| Sales Commissions & Incentives | ₹0.20 Cr | ₹17,550 Cr | ₹0.14 Cr | ₹0.14 Cr |
| Freight and Forwarding | ₹2.39 Cr | ₹92,161 Cr | ₹0.94 Cr | ₹0.94 Cr |
| Handling and Clearing Charges | - | - | - | - |
| Other Selling Expenses | - | ₹401 Cr | ₹0.00 Cr | ₹0.00 Cr |
| Miscellaneous Expenses | ₹0.60 Cr | ₹28,248 Cr | ₹0.17 Cr | ₹0.17 Cr |
| Bad debts /advances written off | - | - | - | - |
| Provision for doubtful debts | ₹0.02 Cr | - | - | - |
| Losson disposal of fixed assets(net) | ₹0.01 Cr | - | ₹0.00 Cr | ₹0.00 Cr |
| Losson foreign exchange fluctuations | - | - | - | - |
| Losson sale of non-trade current investments | - | - | - | - |
| Other Miscellaneous Expenses | ₹0.57 Cr | ₹28,248 Cr | ₹0.17 Cr | ₹0.17 Cr |
| Less: Expenses Capitalised | - | - | - | - |
| Total Expenditure | ₹84 Cr | ₹5,150,123 Cr | ₹27 Cr | ₹27 Cr |
| Operating Profit (Excl OI) | ₹42 Cr | ₹1,251,750 Cr | ₹8.74 Cr | ₹8.74 Cr |
| Other Income | ₹3.07 Cr | ₹390,970 Cr | ₹1.17 Cr | ₹1.17 Cr |
| Interest Received | ₹0.07 Cr | ₹11,349 Cr | ₹0.11 Cr | ₹0.11 Cr |
| Dividend Received | - | - | - | - |
| Profit on sale of Fixed Assets | - | - | - | - |
| Profits on sale of Investments | - | - | - | - |
| Provision Written Back | - | - | - | - |
| Foreign Exchange Gains | ₹2.15 Cr | ₹216,613 Cr | ₹0.73 Cr | ₹0.73 Cr |
| Others | ₹0.86 Cr | ₹163,008 Cr | ₹0.32 Cr | ₹0.32 Cr |
| Operating Profit | ₹45 Cr | ₹1,642,720 Cr | ₹9.91 Cr | ₹9.91 Cr |
| Interest | ₹0.61 Cr | ₹54,250 Cr | ₹0.20 Cr | ₹0.20 Cr |
| InterestonDebenture / Bonds | - | - | - | - |
| Interest on Term Loan | ₹0.54 Cr | - | - | - |
| Intereston Fixed deposits | - | - | - | - |
| Bank Charges etc | ₹0.06 Cr | ₹4,913 Cr | ₹0.03 Cr | ₹0.03 Cr |
| Other Interest | ₹0.01 Cr | ₹49,338 Cr | ₹0.18 Cr | ₹0.18 Cr |
| PBDT | ₹44 Cr | ₹1,588,469 Cr | ₹9.70 Cr | ₹9.70 Cr |
| Depreciation | ₹6.11 Cr | ₹229,473 Cr | ₹1.04 Cr | ₹1.04 Cr |
| Profit Before Taxation & Exceptional Items | ₹38 Cr | ₹1,358,996 Cr | ₹8.67 Cr | ₹8.67 Cr |
| Exceptional Income / Expenses | - | - | - | - |
| Profit Before Tax | ₹38 Cr | ₹1,358,996 Cr | ₹8.67 Cr | ₹8.67 Cr |
| Provision for Tax | ₹10 Cr | ₹311,940 Cr | ₹2.43 Cr | ₹2.43 Cr |
| Current Income Tax | ₹9.33 Cr | ₹317,573 Cr | ₹2.19 Cr | ₹2.19 Cr |
| Deferred Tax | ₹0.67 Cr | ₹-5,633 Cr | ₹0.24 Cr | ₹0.24 Cr |
| Other taxes | ₹0.05 Cr | - | - | - |
| Profit After Tax | ₹28 Cr | ₹1,047,056 Cr | ₹6.24 Cr | ₹6.24 Cr |
| Extra items | - | - | - | - |
| Minority Interest | - | - | - | - |
| Share of Associate | - | - | - | - |
| Other Consolidated Items | - | - | - | - |
| Consolidated Net Profit | ₹28 Cr | ₹1,047,056 Cr | ₹6.24 Cr | ₹6.24 Cr |
| Adjustments to PAT | - | - | - | - |
| Profit Balance B/F | ₹59 Cr | ₹1,800,323 Cr | ₹13 Cr | ₹13 Cr |
| Appropriations | ₹87 Cr | ₹2,847,379 Cr | ₹19 Cr | ₹19 Cr |
| General Reserves | - | - | - | - |
| Proposed Equity Dividend | - | - | - | - |
| Corporate dividend tax | - | - | - | - |
| Other Appropriation | ₹0.58 Cr | ₹233,318 Cr | ₹1.09 Cr | ₹1.09 Cr |
| Equity Dividend % | - | ₹15.00 | ₹12.50 | ₹12.50 |
| Earnings Per Share | ₹21.89 | ₹11.67 | ₹6.95 | ₹6.95 |
| Adjusted EPS | ₹21.89 | ₹8.66 | ₹5.16 | ₹5.16 |
Compare Income Statement of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹628.5 Cr | -2.8% | -9.9% | -36% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,471.0 Cr | 0.3% | 4.1% | -9.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,294.0 Cr | -1.7% | 8.5% | 13.2% | Stock Analytics | |
| CIPLA | ₹127,946.0 Cr | -3.4% | 3% | 4.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,691.0 Cr | 0.7% | -0.5% | 7.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,214.0 Cr | 0.2% | -1.1% | -3.6% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -2.8% |
-9.9% |
-36% |
| SENSEX | 1% |
3.3% |
4.5% |
You may also like the below Video Courses